Endo Investors
333 South Hope Street, 55th Floor, Los Angeles, CA, 90071, United States
Overview
Endo makes investments in game-changing early stage companies improving outcomes for large patient populations affected by various chronic diseases. Endo is backed by a group of mission-oriented investors and was created in response to a deficit of early-stage capital focused on companies impacting diabetes and other major global health issues.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 0
Investment portfolio
- Cecelia Health
Led · Series B · Aug 2020
Cecelia Health is a NYC-based technology-enabled company that provides coaching and telemedicine services for diabetes and other chronic diseases. Its core product is a digital health platform staffed by expert clinicians—CDCESs and endocrinologists—that supports remote patient care and chronic disease management. The company has logged over one million remote patient interactions, reflecting significant usage of its telehealth services. Cecelia plans to expand its digital health capabilities and scale adoption of its technology-enabled coaching and telemedicine solutions using the new capital. It intends to launch a commercial Virtual Clinic that will provide CGM training, medication-adherence education, lifestyle and behavior-change support, and mental-health screening and counseling. Algorithms will recommend dosage and titration changes that are reviewed and approved by Cecelia’s clinicians, and the Virtual Clinic will be supported by a national network of diabetes professionals. Fit4D is a NYC-based diabetes management technology services company that provides a patient-centric, technology-enabled coaching solution. Led by CEO David Weingard, its purpose-built coaching platform enables Certified Diabetes Educator (CDE) clinicians to scale their reach and deliver personalized, one-on-one diabetes management programs through an optimized mix of humans and technology. The Fit4D clinical team is comprised primarily of CDEs with clinical credentials such as nurses, registered dietitians, pharmacists, exercise physiologists and social workers. The company partners with health plans and providers and has engaged in joint initiatives with the Juvenile Diabetes Research Foundation, the American Diabetes Association, the Diabetes Research Institute and the American Association of Diabetes Educators. In April 2018 the company raised $4M in expansion financing and intends to use the funds to consolidate its market position. Fit4D is a NYC-based digital health company focused on people living with diabetes, delivering patient programs through a combination of a technology platform and human-based touch points. Its clinical team includes dietitians, exercise physiologists, nurses, social workers, and many certified diabetes educators (CDEs) who provide personalized care. The platform supports electronic interactions in patient-preferred modalities (phone, email, text, web, video) and delivers content in preferred formats and at preferred times to address patient-specific issues. Clients include pharmaceutical companies, payers, providers and wellness companies. Fit4D secured a Series A of undisclosed amount backed by SJF Ventures, Sovereign Health System and Blue Cross and Blue Shield of Nebraska. The company intends to use the funds to expand distribution across new customer channels and to leverage the platform to improve health outcomes for other chronic diseases; it is led by CEO David Weingard and is a member of the StartUp Health Academy.
Team
No current team members are available.